C4601003 - A PHASE 3, MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLINDED TRIAL TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY, AND LOT CONSISTENCY OF A 6-VALENT OSPA-BASED LYME DISEASE VACCINE IN HEALTHY PARTICIPANTS ≥5 YEARS OF AGE
This important study is looking into a new vaccine designed to protect people from Lyme disease, a condition caused by bacteria spread by tick bites. The vaccine, called VLA15, is being tested in people aged 5 and above. Researchers want to understand if the vaccine successfully stops people from getting Lyme disease. They are also carefully checking for any side effects, both mild ones like pain where the injection was given, and more serious ones. Another key part of the study is to see how the immune system (the body's natural defence) responds to the vaccine. Participants will be compared to others who receive a dummy injection (placebo) to fairly assess the vaccine's effects.
Em resumo
Sobre o que é este estudo?
Imagine a shield that could help protect you from Lyme disease, a condition caught from tick bites that can cause various health problems. This study is all about testing a new vaccine, called VLA15, which aims to be that shield. The main goal is to find out if this vaccine can really stop people from getting Lyme disease and to make sure it's safe to use.
Researchers are giving the vaccine to healthy people aged 5 years and older, and then carefully watching to see if they get Lyme disease. They're also comparing this group to another group who receive a 'dummy' injection (called a placebo), which looks just like the vaccine but doesn't contain the active ingredients. This helps them understand if any effects they see are truly due to the vaccine or if they would have happened anyway.
By doing this study, scientists hope to gather enough information to show if the VLA15 vaccine is an effective and safe way to prevent Lyme disease. If successful, this could offer a new way to protect many people from this illness.
Pontos principais
- This study is testing a new vaccine (VLA15) for Lyme disease.
- It's open to healthy people aged 5 and over.
- Researchers want to know if the vaccine prevents Lyme disease and if it's safe.
- Some participants will receive the vaccine, others a dummy injection (placebo).
- You'll have regular check-ups and blood tests if you take part.
- Your participation could help develop a new way to prevent Lyme disease.
Quem pode ser elegível?
To join this study, people generally need to be at least 18 years old. There isn't an upper age limit, so adults of many ages might be able to take part. The study is open to both men and women.
It's important that participants are healthy before joining the study. This helps researchers focus on how the vaccine affects healthy individuals. Exact health requirements will be discussed in detail by the study team, as some medical conditions or medications might mean someone can't join.
Este estudo pode ser adequado para você?
Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.
- Você tem pelo menos 18 anos?
- Você está geralmente em boa saúde?
- Are you able to attend appointments regularly at the study clinic?
- Are you willing to potentially receive either the vaccine or a placebo?
- Are you comfortable having blood samples taken during the study?
O que envolve a participação?
If you decide to take part, you'll be given either the new vaccine (VLA15) or a dummy injection (placebo). Neither you nor the study staff will know which one you receive. You'll need to attend several appointments at the clinic for injections and check-ups. During these visits, the study team will carefully monitor your health, ask about any symptoms or side effects you might have, and take blood samples to see how your body is reacting to the vaccine. There will also be a follow-up period to track your health over time. The study will last for a set period, which will be explained in full, probably over several months or even a few years.
Riscos e benefícios potenciais
Localizações (5)
- —Não verificadoSuécia
- —Não verificadoPaíses Baixos
- —Não verificadoPolônia
- —Não verificadoFinlândia
- —Não verificadoAlemanha
Perguntas frequentes
O que é a doença de Lyme?
Lyme disease is an infection caused by bacteria spread through the bite of infected ticks, which can cause symptoms like a rash, fever, and if untreated, more serious problems affecting joints, the heart, or nervous system.
O que é um placebo?
A placebo is a 'dummy' treatment that looks exactly like the real vaccine but doesn't contain any active ingredients. It's used to fairly compare the effects of the actual vaccine.
Will I know if I've received the vaccine or the placebo?
No, neither you nor the study staff will know whether you've received the vaccine or the placebo. This is to ensure the study results are fair and unbiased.
What are the main things researchers are looking for?
They mainly want to see if the vaccine prevents Lyme disease, if it's safe (looking for side effects), and how your body's immune system responds to it.
Who is sponsoring this study?
The information provided does not specify the sponsor, but clinical trials are typically sponsored by pharmaceutical companies or research organisations.
Como saber mais
Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.
Interessado em participar?
Discussão
Discussão da comunidade
Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.